|
Market Closed -
Swiss Exchange
11:36:27 2026-09-18 EDT
|
5-day change | 1st Jan Change | ||
| 20.20 CHF | +6.88% |
|
+3.86% | +25.25% |
Company Valuation: Kinarus Therapeutics Holding AG
Data adjusted to current consolidation scope
| Fiscal Period: December | 2022 | 2023 |
|---|---|---|
| Market Cap 1 | 12.75 | 0.5241 |
| Change | - | -95.89% |
| Enterprise Value (EV) 1 | 14.41 | 0.5151 |
| Change | - | -96.43% |
| P/E | -0.23x | -0.01x |
| PBR | 1.91x | -1.68x |
| PEG | -0x | 0x |
| Capitalization / Revenue | 3,821,719x | - |
| EV / Revenue | - | - |
| EV / EBITDA | - | - |
| EV / EBIT | -7.83x | -0.12x |
| EV / FCF | - | - |
| FCF Yield | - | - |
| Dividend per Share 2 | - | - |
| Rate of return | - | - |
| EPS 2 | -221.6 | -176.4 |
| Distribution rate | - | - |
| Net sales | 3.336 | - |
| EBITDA | -0.318 | -3.862 |
| EBIT 1 | -1.84 | -4.351 |
| Net income 1 | -34.73 | -49.38 |
| Net Debt 1 | 1.658 | -0.009 |
| Reference price 2 | 51.07 | 1.79 |
| Nbr of stocks (in thousands) | 250 | 292 |
| Announcement Date | 5/31/23 | 4/17/24 |
1CHF in Million2CHF
Estimates
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CURE Stock
- Valuation Kinarus Therapeutics Holding AG
Select your edition
All financial news and data tailored to specific country editions
